RE: WF/C718 May 2018 14:37
Define a diehard Inanaco? Individuals who can afford to build a substantial holding? Very dangerous naming individuals and leaving many others out who have a substantial portion of their wealth tied up here.
I would have thought whilst our second platform is still in clinical development, collaborations and partnerships being signed to perfect the treatment building a large ii base is vital to future plans and funding.
We as PIs couldnt even raise �2m in the OO. PIs here by and large trade stunting any rises, the company has a stratagy, cancer vaccines still fail to escape further evaluation, it is a difficult one. I think to a certain extent we are victims,of Scancells success, clinical development takes time and money and one thing we all probably agree on money has not been wasted.
Lets not forget the cancer market has changed and is unrecognisable to what we have now.